Vident Investment Advisory, LLC Lyell Immunopharma, Inc. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.97 - $3.58 $3,110 - $5,652
-1,579 Reduced 0.71%
221,112 $521,000
Q4 2022

Feb 14, 2023
BUY
$2.78 - $8.09 $251,409 - $731,619
90,435 Added 68.38%
222,691 $772,000
Q3 2022

Nov 14, 2022
SELL
$5.54 - $8.27 $78,496 - $117,177
-14,169 Reduced 9.68%
132,256 $969,000
Q2 2022

Aug 15, 2022
BUY
$3.68 - $6.8 $538,844 - $995,690
146,425 New
146,425 $955,000

Others Institutions Holding LYEL

# of Institutions
121
Shares Held
142M
Call Options Held
18.1K
Put Options Held
200
View Full List

About Lyell Immunopharma, Inc.

LYEL Quotes by TradingView
  • Ticker LYEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 247,824,992
  • Market Cap $151M
  • Description
  • Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...
More about LYEL
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email